Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06949904
PHASE1/PHASE2

The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia

Sponsor: Mian Muhammad Hassan Ahmed

View on ClinicalTrials.gov

Summary

The goal of this study is to compare the mean length of hospital stay between children with pneumonia receiving melatonin as an adjuvant therapy and those receiving standard of care alone. The hypothesis is that combining oral melatonin with standard treatment can reduce the length of hospital stay as compared to standard of care alone. The control group will receive standard treatment (antibiotic) while the intervention group will receive standard treatment plus melatonin for 14 days.

Key Details

Gender

All

Age Range

1 Month - 12 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-05

Completion Date

2026-01

Last Updated

2025-04-29

Healthy Volunteers

No

Interventions

DRUG

Melatonin

1 mg/dose in infants and 2.5 to 3mg/dose in children three times a day for 14 days

Locations (1)

Pakistan Institute of Medical Sciences

Islamabad, Islamabad, Pakistan